Just joined Aditum Bio as CEO-in-Residence; will lead/advise multiple companies across the portfolio.ย Privileged to work with great drug development team and visionary partners who've built this innovative firm.ย Also excited to work with @RavneeshSachdev , CBO at Aditum.
I can only imagine how difficult this day is for so many. Wish I had words that would ease some of the pain. My prayers for those who died, the safe return of hostages, the families of those impacted, and peace for all in the region who just want to live a normal, happy life. ๐๐ฝ
For those who believe more should be done on immigration, please consider the video below. We need government officials to work together for the country's benefit rather than killing bipartisan legislation in hopes of campaign strength.
BREAKING: In a stunning admission, one of the most conservative Senators, Senator James Lankford, admits that it was Donald Trump who sabotaged the toughest border security legislation proposed in decades. Retweet to make sure every American sees this
@thayerschool@columbiaclimate@AbramsonAlexis Alexis has been a devoted and unflappable leader, from her first month learning that a new building was 10 feet out of place to facing covid in her first year to months of diplomacy across campus as Dartmouth re-organizes Arts and Sciences. You will be missed, my friend!
@X March 22 was my last day at Upstream Bio. It has been a privilege to build and lead the amazing Upstream team thus far.ย I wish the very best to the team in continuing to develop UPB-101 for the patients we all serve.ย I will be cheering for Upstream all the way.
We are excited to announce dosing of the first patients in a Phase 2 clinical trial of verekitug (UPB-101) in severe asthma. Read the full press release here: https://t.co/AgKik3L6k7
We are excited to announce dosing of the first patients in a Phase 2 clinical trial of verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Read the full press release here: https://t.co/fgou68lv8I
Upstreamโs CEO, @SamTruex, shares more about advancement of UPB-101 and its potential as a best-in-class TSLP-inhibitor in a recent article by BioSpace. Read the full article here: https://t.co/V56yH4NXq8
Fantastic pre-Thanksgiving multi-cultural potluck today @UpstreamBio . And team donation to local food pantry. We have so much for which to be thankful.
We are excited to announce positive Phase 1b Interim Data in Asthma and Company Progress Toward Phase 2. Read the full press release here: https://t.co/2oT3ykRIXL